Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | CASP1 | P29466 | 2/20 | 0.38 |
| ▸ | CASP7 | P55210 | 2/20 | 0.38 |
| ▸ | HBB | P68871 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5605449 | 0.85 | PRKCI (0.42) | PRKCINUDT1 | |
| SCHEMBL5605028 | 0.85 | PRKCI (0.42) | PRKCINUDT1 | |
| SCHEMBL5606146 | 0.83 | PRKCI (0.41) | PRKCI | |
| SCHEMBL21154375 | 0.83 | PRKCI (0.41) | PRKCI | |
| SCHEMBL5605747 | 0.83 | PRKCI (0.41) | PRKCI | |
| SCHEMBL10829034 | 0.83 | TDP1 (0.44) | IDO1ALDH1A1HSD17B10TDP1POLB | |
| SCHEMBL14320079 | 0.79 | IDO1 (0.42) | IDO1ALDH1A1HSD17B10CYP3A4TDP1 | |
| SCHEMBL5084584 | 0.77 | PRKCI (0.46) | PRKCIALDH1A1HSD17B10CYP3A4TDP1 | |
| SCHEMBL23626051 | 0.75 | IDO1 (0.41) | PRKCIIDO1ALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL5085231 | 0.75 | PRKCI (0.45) | PRKCIALDH1A1HSD17B10CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337534-A1 | NITROGEN-CONTAINING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| US-9818959-B2 | Metal-assisted delayed fluorescent emitters containing tridentate ligands | Arizona Board of Regents on behlaf of Arizona State University (US) | 2017-11-14 | — | — | US | disclosed |
| WO-2012019106-A2 | POSITIVE AND NEGATIVE MODULATORS OF NMDA RECEPTORS | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2012-02-09 | — | — | WO | disclosed |
| US-8017774-B2 | Producing method for iridium complex | CANON KABUSHIKI KAISHA (JP) | 2011-09-13 | — | — | US | disclosed |
| EP-1089999-A4 | (HETEROCYCLIC) METHYL SUBSTITUTED CARBAPENEM ANTIBACTERIALS | MERCK & CO INC (US) | 2002-12-04 | — | — | EP | disclosed |
| US-6291448-B1 | CARBAPENEM NUCLEUS IS SUBSTITUTED AT THE 2-POSITION WITH FUSED BI- AND TRICYCLIC 2,2-DIOXO-3-X-2-THIA-1-AZA-CYCLOPENTA RING SYSTEMS LINKED THROUGH A CH2 GROUP. | MERCK & CO., INC. | 2001-09-18 | — | — | US | disclosed |
| EP-1089999-A1 | (HETEROCYCLIC) METHYL SUBSTITUTED CARBAPENEM ANTIBACTERIALS | Merck & Co., Inc. (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-1999067241-A1 | (HETEROCYCLIC) METHYL SUBSTITUTED CARBAPENEM ANTIBACTERIALS | MERCK & CO., INC. (US) | 1999-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337534-A1 | NITROGEN-CONTAINING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS THEREOF | NUDC, SLC29A2, SLC6A19 | PRKCI 4462/4885IDO1 3311/4885ALDH1A1 3779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.